Last updated on September 2014

Study of Radium-223 Dichloride Versus Placebo and Treatment With Exemestane / Everolimus in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer


Find a site near you

Start Over

Bayer Clinical Trials Contact

Guildford, United Kingdom
5.49miles
  Connect »